SE9003151D0 - Nucleoside derivatives - Google Patents
Nucleoside derivativesInfo
- Publication number
- SE9003151D0 SE9003151D0 SE9003151A SE9003151A SE9003151D0 SE 9003151 D0 SE9003151 D0 SE 9003151D0 SE 9003151 A SE9003151 A SE 9003151A SE 9003151 A SE9003151 A SE 9003151A SE 9003151 D0 SE9003151 D0 SE 9003151D0
- Authority
- SE
- Sweden
- Prior art keywords
- pct
- date
- ch2n3
- ch2sh
- ch2f
- Prior art date
Links
- 150000003833 nucleoside derivatives Chemical class 0.000 title 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 4
- VUWZPRWSIVNGKG-UHFFFAOYSA-N fluoromethane Chemical compound F[CH2] VUWZPRWSIVNGKG-UHFFFAOYSA-N 0.000 abstract 2
- CBOIHMRHGLHBPB-UHFFFAOYSA-N hydroxymethyl Chemical group O[CH2] CBOIHMRHGLHBPB-UHFFFAOYSA-N 0.000 abstract 2
- 125000004055 thiomethyl group Chemical group [H]SC([H])([H])* 0.000 abstract 2
- 229910019142 PO4 Inorganic materials 0.000 abstract 1
- 125000002015 acyclic group Chemical group 0.000 abstract 1
- 125000004423 acyloxy group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 230000000840 anti-viral effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000001177 diphosphate Substances 0.000 abstract 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 abstract 1
- 235000011180 diphosphates Nutrition 0.000 abstract 1
- 208000002672 hepatitis B Diseases 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 229940127073 nucleoside analogue Drugs 0.000 abstract 1
- 239000010452 phosphate Substances 0.000 abstract 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 abstract 1
- 235000021317 phosphate Nutrition 0.000 abstract 1
- 239000001226 triphosphate Substances 0.000 abstract 1
- 235000011178 triphosphate Nutrition 0.000 abstract 1
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 abstract 1
- 241001430294 unidentified retrovirus Species 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
- C07F9/6512—Six-membered rings having the nitrogen atoms in positions 1 and 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
- C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Priority Applications (15)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9003151A SE9003151D0 (sv) | 1990-10-02 | 1990-10-02 | Nucleoside derivatives |
IE337491A IE913374A1 (en) | 1990-10-02 | 1991-09-26 | Nucleoside derivatives |
HU93964A HUT63851A (en) | 1990-10-02 | 1991-09-27 | Process for producing nucleoside derivatives and pharmaceutical compositions comprising such compounds |
CA002093020A CA2093020A1 (en) | 1990-10-02 | 1991-09-27 | Nucleoside derivatives |
EP91917480A EP0554274A1 (en) | 1990-10-02 | 1991-09-27 | Nucleoside derivatives |
US08/030,168 US5473063A (en) | 1990-10-02 | 1991-09-27 | Synthesis of furanosyl compounds useful as intermediates in preparation of nucleoside analogues |
KR1019930701006A KR930702371A (ko) | 1990-10-02 | 1991-09-27 | 뉴클레오시드 유도체 |
PCT/SE1991/000653 WO1992006102A1 (en) | 1990-10-02 | 1991-09-27 | Nucleoside derivatives |
AU86410/91A AU8641091A (en) | 1990-10-02 | 1991-09-27 | Nucleoside derivatives |
JP3516127A JPH06501261A (ja) | 1990-10-02 | 1991-09-27 | ヌクレオシド誘導体 |
PT99130A PT99130A (pt) | 1990-10-02 | 1991-10-01 | Processo de preparacao de derivados nucleosidos, dos seus intermediarios e de composicoes farmaceuticas |
NO931264A NO931264D0 (no) | 1990-10-02 | 1993-04-01 | Nukleosid-derivater |
US08/516,551 US5747473A (en) | 1990-10-02 | 1995-08-18 | L-nucleoside analogues and pharmaceutical compositions |
US09/041,135 US5952500A (en) | 1990-10-02 | 1998-03-12 | Nucleoside derivatives |
US09/334,756 US6121431A (en) | 1990-10-02 | 1999-06-17 | Nucleoside derivatives |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9003151A SE9003151D0 (sv) | 1990-10-02 | 1990-10-02 | Nucleoside derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9003151D0 true SE9003151D0 (sv) | 1990-10-02 |
Family
ID=20380539
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9003151A SE9003151D0 (sv) | 1990-10-02 | 1990-10-02 | Nucleoside derivatives |
Country Status (11)
Country | Link |
---|---|
US (4) | US5473063A (sv) |
EP (1) | EP0554274A1 (sv) |
JP (1) | JPH06501261A (sv) |
KR (1) | KR930702371A (sv) |
AU (1) | AU8641091A (sv) |
CA (1) | CA2093020A1 (sv) |
HU (1) | HUT63851A (sv) |
IE (1) | IE913374A1 (sv) |
PT (1) | PT99130A (sv) |
SE (1) | SE9003151D0 (sv) |
WO (1) | WO1992006102A1 (sv) |
Families Citing this family (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ234534A (en) * | 1989-07-17 | 1994-12-22 | Univ Birmingham | Pyrimidine 4'-thionucleoside derivatives and their preparation; intermediates therefor |
US5728575A (en) | 1990-02-01 | 1998-03-17 | Emory University | Method of resolution of 1,3-oxathiolane nucleoside enantiomers |
US5521163A (en) * | 1990-07-13 | 1996-05-28 | University Of Birmingham | Antiviral pyrimidine nucleosides and methods for using same |
SE9003151D0 (sv) * | 1990-10-02 | 1990-10-02 | Medivir Ab | Nucleoside derivatives |
US5444063A (en) * | 1990-12-05 | 1995-08-22 | Emory University | Enantiomerically pure β-D-dioxolane nucleosides with selective anti-Hepatitis B virus activity |
US6235887B1 (en) | 1991-11-26 | 2001-05-22 | Isis Pharmaceuticals, Inc. | Enhanced triple-helix and double-helix formation directed by oligonucleotides containing modified pyrimidines |
EP0637965B1 (en) * | 1991-11-26 | 2002-10-16 | Isis Pharmaceuticals, Inc. | Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines |
TW393513B (en) * | 1991-11-26 | 2000-06-11 | Isis Pharmaceuticals Inc | Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines |
GB9218810D0 (en) * | 1992-09-04 | 1992-10-21 | Univ Birmingham | Antiviral pyrimidine nucleosides |
WO1994021658A1 (en) * | 1993-03-15 | 1994-09-29 | Kalman Thomas I | Antiviral imidazolinone nucleoside derivatives |
US6200952B1 (en) * | 1993-06-02 | 2001-03-13 | Sciclone Pharmaceuticals, Inc. | Combination therapy method for treating chronic hepatitis B |
FR2709754B1 (fr) * | 1993-09-10 | 1995-12-01 | Centre Nat Rech Scient | Composés 2' ou 3'-déoxy- et 2', 3'-didéoxy-beta-L-pentofuranonucléosides, procédé de préparation et application thérapeutique, notamment anti-virale. |
US20020120130A1 (en) | 1993-09-10 | 2002-08-29 | Gilles Gosselin | 2' or 3' -deoxy and 2', 3' -dideoxy-beta-L-pentofuranonucleo-side compounds, method of preparation and application in therapy, especially as anti- viral agents |
US5587362A (en) * | 1994-01-28 | 1996-12-24 | Univ. Of Ga Research Foundation | L-nucleosides |
AU697612B2 (en) * | 1994-05-31 | 1998-10-15 | Medivir Ab | Post exposure prevention of HIV |
US5612319A (en) * | 1994-05-31 | 1997-03-18 | Medivir Ab | Postexposure prevention of HIV infection or seroconversion |
GB9413724D0 (en) * | 1994-07-07 | 1994-08-24 | Wellcome Found | Therapeutic nucleosides |
US5811408A (en) * | 1994-07-12 | 1998-09-22 | Yamasa Corporation | 2'-deoxy-2'-(substituted or unsubstituted)methylidene-4'-thionucleosides |
DE69533856T2 (de) * | 1994-10-24 | 2005-12-08 | Genencor International, Inc., Palo Alto | L-pyranosyl-nukleoside |
US5559101A (en) * | 1994-10-24 | 1996-09-24 | Genencor International, Inc. | L-ribofuranosyl nucleosides |
US5703058A (en) * | 1995-01-27 | 1997-12-30 | Emory University | Compositions containing 5-fluoro-2',3'-didehydro-2',3'-dideoxycytidine or a mono-, di-, or triphosphate thereof and a second antiviral agent |
US6391859B1 (en) | 1995-01-27 | 2002-05-21 | Emory University | [5-Carboxamido or 5-fluoro]-[2′,3′-unsaturated or 3′-modified]-pyrimidine nucleosides |
US5808040A (en) * | 1995-01-30 | 1998-09-15 | Yale University | L-nucleosides incorporated into polymeric structure for stabilization of oligonucleotides |
ES2276404T3 (es) | 1995-06-07 | 2007-06-16 | Emory University | Nucleosidos con actividad antivirus de la hepatitis-b. |
CN1201463A (zh) * | 1995-11-02 | 1998-12-09 | 株式会社钟根堂 | 新型核苷衍生物及其制备方法 |
GB9600143D0 (en) | 1996-01-05 | 1996-03-06 | Wellcome Found | Therapeutic compounds |
US6703394B2 (en) | 1996-02-16 | 2004-03-09 | Medivir Ab | Acyclic nucleoside derivatives |
US5869493A (en) | 1996-02-16 | 1999-02-09 | Medivir Ab | Acyclic nucleoside derivatives |
US5753789A (en) * | 1996-07-26 | 1998-05-19 | Yale University | Oligonucleotides containing L-nucleosides |
US6509320B1 (en) * | 1996-10-16 | 2003-01-21 | Icn Pharmaceuticals, Inc. | Purine L-nucleosides, analogs and uses thereof |
ATE271063T1 (de) * | 1996-10-16 | 2004-07-15 | Icn Pharmaceuticals | Purin-l-nukleoside, deren analoga und verwendungen |
EP1072607A3 (en) * | 1996-10-16 | 2001-09-12 | ICN Pharmaceuticals, Inc. | Purine L-nucleosides, analogs and uses therof |
EP0970100B1 (en) | 1997-02-13 | 2003-11-12 | Glaxo Group Limited | Benzimidazole derivatives |
GB9807354D0 (en) * | 1998-04-07 | 1998-06-03 | Glaxo Group Ltd | Antiviral compound |
GB9807355D0 (en) | 1998-04-07 | 1998-06-03 | Glaxo Group Ltd | Antiviral compound |
GB9821058D0 (en) * | 1998-09-28 | 1998-11-18 | Univ Cardiff | Chemical compound |
YU25500A (sh) | 1999-05-11 | 2003-08-29 | Pfizer Products Inc. | Postupak za sintezu analoga nukleozida |
US7019129B1 (en) | 2000-05-09 | 2006-03-28 | Biosearch Technologies, Inc. | Dark quenchers for donor-acceptor energy transfer |
AU2003251524A1 (en) * | 2002-06-17 | 2003-12-31 | Isis Pharmaceuticals, Inc. | Carbocyclic nucleoside analogs as RNA-antivirals |
CA2594229A1 (en) * | 2004-12-30 | 2006-07-06 | Medivir Ab | 2',3'-dideoxy-3'-c-hyroxymethylcytidine and prodrugs thereof for the treatment of drug escape mutant hiv |
EP2268608A4 (en) | 2008-04-01 | 2012-01-11 | Biosearch Technologies Inc | DARK NUCLEIC ACID STABILIZED FLUOROPHORE DEACTIVATOR PROBES |
CN104203969B (zh) | 2012-03-28 | 2016-08-31 | 富士胶片株式会社 | 1-(2-脱氧-2-氟-4-硫代-β-D-***呋喃糖基)胞嘧啶的盐 |
KR20170001722A (ko) | 2012-08-13 | 2017-01-04 | 후지필름 가부시키가이샤 | 1-(2-데옥시-2-플루오로-4-티오-β-D-아라비노푸라노실)시토신의 합성 중간체, 티오뉴클레오시드의 합성 중간체, 및 그들의 제조법 |
WO2015125781A1 (ja) | 2014-02-18 | 2015-08-27 | 富士フイルム株式会社 | チオラン骨格型糖化合物の製造方法およびチオラン骨格型糖化合物 |
JP6204223B2 (ja) | 2014-02-19 | 2017-09-27 | 富士フイルム株式会社 | チオピラノース化合物等の製造方法 |
TWI678373B (zh) | 2014-10-31 | 2019-12-01 | 日商富士軟片股份有限公司 | 硫代核苷衍生物或其鹽及醫藥組合物 |
EP4001283A1 (en) * | 2015-05-12 | 2022-05-25 | F. Hoffmann-La Roche AG | Substituted aminothiazolopyrimidinedione derivatives for the treatment and prophylaxis of virus infection |
SG11201901815WA (en) | 2016-08-31 | 2019-04-29 | Fujifilm Corp | Anti-tumor agent, anti-tumor effect enhancer, and anti-tumor kit |
CA3089728C (en) | 2018-01-29 | 2023-01-10 | Fujifilm Corporation | Antitumor agent for biliary tract cancer and method for treating biliary tract cancer |
CN114409655A (zh) * | 2022-01-26 | 2022-04-29 | 郑州大学 | 3′,4′-不饱和核糖c-核苷类似物及其制备方法 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3116282A (en) * | 1960-04-27 | 1963-12-31 | Upjohn Co | Pyrimidine nucleosides and process |
FR2040177A1 (en) * | 1969-01-31 | 1971-01-22 | Robugen Gmbh | 2-deoxyribosyl-uracil derivs |
US3817982A (en) * | 1971-12-29 | 1974-06-18 | Syntex Inc | 2{40 ,3{40 -unsaturated nucleosides and method of making |
US4247544A (en) * | 1979-07-02 | 1981-01-27 | The Regents Of The University Of California | C-5 Substituted uracil nucleosides |
US4267171A (en) * | 1979-07-02 | 1981-05-12 | The Regents Of The University Of California | C-5 Substituted cytosine nucleosides |
JPS57146798A (en) * | 1981-03-06 | 1982-09-10 | Yamasa Shoyu Co Ltd | Hexosyl nucleoside derivative |
US4724232A (en) * | 1985-03-16 | 1988-02-09 | Burroughs Wellcome Co. | Treatment of human viral infections |
EP0286825A3 (en) * | 1987-03-18 | 1989-04-12 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Use of 3'-fluro-3' deoxythymidine for the manufacture of a medicament for the treatment of virus infections |
SE8701605D0 (sv) * | 1987-04-16 | 1987-04-16 | Astra Ab | Novel medicinal compounds |
SE8704298D0 (sv) * | 1987-11-03 | 1987-11-03 | Astra Ab | Compounds for use in therapy |
SE8802173D0 (sv) * | 1988-06-10 | 1988-06-10 | Astra Ab | Pyrimidine derivatives |
FI95384C (sv) * | 1989-04-06 | 1996-01-25 | Squibb Bristol Myers Co | Förfarande för framställning 3'-deoxi-3'-substituerade metylnukleosider och mellanprodukter som används i förfarandet |
JPH03223264A (ja) * | 1990-01-30 | 1991-10-02 | Nippon Kayaku Co Ltd | 新規なシクロペンタン誘導体及びその製造法 |
SE9003151D0 (sv) * | 1990-10-02 | 1990-10-02 | Medivir Ab | Nucleoside derivatives |
ATE273700T1 (de) * | 1993-05-21 | 2004-09-15 | Us Gov Health & Human Serv | Neues verfahen zur hemmung der replication der virus - abhängigen reverse transciptase durch verwendung von dideoxydenucleotide-synthese inhibitoren |
US5521161A (en) * | 1993-12-20 | 1996-05-28 | Compagnie De Developpment Aguettant S.A. | Method of treating HIV in humans by administration of ddI and hydroxycarbamide |
-
1990
- 1990-10-02 SE SE9003151A patent/SE9003151D0/sv unknown
-
1991
- 1991-09-26 IE IE337491A patent/IE913374A1/en unknown
- 1991-09-27 JP JP3516127A patent/JPH06501261A/ja active Pending
- 1991-09-27 WO PCT/SE1991/000653 patent/WO1992006102A1/en not_active Application Discontinuation
- 1991-09-27 HU HU93964A patent/HUT63851A/hu unknown
- 1991-09-27 US US08/030,168 patent/US5473063A/en not_active Expired - Fee Related
- 1991-09-27 KR KR1019930701006A patent/KR930702371A/ko not_active Application Discontinuation
- 1991-09-27 CA CA002093020A patent/CA2093020A1/en not_active Abandoned
- 1991-09-27 EP EP91917480A patent/EP0554274A1/en not_active Ceased
- 1991-09-27 AU AU86410/91A patent/AU8641091A/en not_active Abandoned
- 1991-10-01 PT PT99130A patent/PT99130A/pt not_active Application Discontinuation
-
1995
- 1995-08-18 US US08/516,551 patent/US5747473A/en not_active Expired - Fee Related
-
1998
- 1998-03-12 US US09/041,135 patent/US5952500A/en not_active Expired - Fee Related
-
1999
- 1999-06-17 US US09/334,756 patent/US6121431A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US5473063A (en) | 1995-12-05 |
US5952500A (en) | 1999-09-14 |
WO1992006102A1 (en) | 1992-04-16 |
HUT63851A (en) | 1993-10-28 |
EP0554274A1 (en) | 1993-08-11 |
CA2093020A1 (en) | 1992-04-03 |
IE913374A1 (en) | 1992-04-08 |
PT99130A (pt) | 1992-08-31 |
US6121431A (en) | 2000-09-19 |
US5747473A (en) | 1998-05-05 |
AU8641091A (en) | 1992-04-28 |
KR930702371A (ko) | 1993-09-08 |
JPH06501261A (ja) | 1994-02-10 |
HU9300964D0 (en) | 1993-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE9003151D0 (sv) | Nucleoside derivatives | |
PA8483101A1 (es) | Compuestos quimicos | |
FI930753A0 (fi) | Nya fosfolipidderivat av nukleosider, deras framstaellning och deras anvaendning saosom antivirala laekemedel | |
NO920210L (no) | Antivirale pyrimidinnukleosider | |
DK0671912T3 (da) | Injicerbare præparater baseret på taxanderivater | |
NL300241I1 (nl) | Hydroxymethyl(methyleencyclopentyl)uurines en -pyrimidines. | |
ATE254132T1 (de) | Antivirale pyrimidin nucleoside derivate | |
ATE124412T1 (de) | Antivirusderivate von (phosphonmethoxy)methoxy purin/pyrimidin. | |
ES2062558T3 (es) | Compuestos contra el cancer. | |
DE69202286D1 (de) | Verfahren zur Färbung keratinischer Fasern mit Isatin oder Isatinderivaten zusammen mit Aminopyrimidin oder Aminopyridin und Färbemittel. | |
PT97478A (pt) | Processo de producao de derivados n-(3-fluoro-2-fosfonilmetoxipropilo) de bases puricas e pirimidicas heterociclicas e de composicoes farmaceuticas que os contem | |
SE8603099L (sv) | Distamycinderivat och forfarande for deras framstellning | |
ES8401037A1 (es) | "procedimiento para la preparacion de nuevos derivados de pirimidina o s-triacina". | |
DK428989D0 (da) | Benzylaminderivater | |
HUP9700436A1 (hu) | Triazingyűrűt tartalmazó anionos vegyületek antivirális hatással | |
DK58288D0 (da) | Cyclopropancarboxylsyreestere, fremgangsmaade til deres fremstilling samt deres anvendelse til bekaempelse af parasitter | |
ES2105285T3 (es) | Nuevos derivados de la adenosina, sus procedimientos de preparacion, composiciones farmaceuticas que los contienen. | |
ES2060970T3 (es) | Nuevos derivados de benzonaftiridina-1,8, su preparacion y las composiciones que les contienen. | |
ES2072536T3 (es) | Derivados de tiazolidina que presentan actividad anti-hipertensiva y su uso en terapeutica. | |
DE69127184D1 (de) | Antiherpes-Zusammensetzungen | |
DE69110528D1 (de) | Chirale 2-(Phosphonomethoxy)propyl-Guanine als antivirale Agentien. | |
MX9303605A (es) | Derivados de azabicicloheptano n-substituidas, su obtencion y uso. | |
ES8501416A1 (es) | 5'-alquil o alquenil-fosfatos de nucleosidos. | |
ATE26268T1 (de) | 2-alkoxyaminosulfonylbenzolsulfonyl-harnstoffderivate. | |
SE8008189L (sv) | Foreningar med antiallergisk och antiulceros verkan, nemligen 1-oxo-1h-tiazolo(3,2-a)pyrimidin-2-karboxamider och mellanprodukter for dessa |